Journal article
Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants
Abstract
Importance: Dose-reduced regimens of direct oral anticoagulants (DOACs) may be used for 2 main purposes: dose-adjusted treatment intended as full-intensity anticoagulation (eg, for stroke prevention in atrial fibrillation [AF] in patients requiring dose reduction) or low-intensity treatment (eg, extended-duration treatment of venous thromboembolism [VTE]). We reviewed randomized clinical trials (RCTs) to understand the scenarios in which …
Authors
Bikdeli B; Tajrishi FZ; Sadeghipour P; Talasaz AH; Fanikos J; Lippi G; Siegal DM; Eikelboom JW; Monreal M; Jimenez D
Journal
JAMA Cardiology, Vol. 7, No. 7, pp. 747–759
Publisher
American Medical Association (AMA)
Publication Date
July 1, 2022
DOI
10.1001/jamacardio.2022.1292
ISSN
2380-6583